ARTICLE | Clinical News
NMP22 BladderChek Test regulatory update
July 18, 2005 7:00 AM UTC
MZT received Japanese marketing approval for NMP22 BladderCheck test, an assay to detect nuclear matrix protein NMP22 in urine, to diagnose bladder cancer. BladderChek is approved in the U.S., Europe ...